CEACAM5 and anemia: We found that patients with a clinically negative nodal disease, without anemia during treatment, with a long interval (>8 weeks) between radiotherapy and surgery, with post-CRT CEA levels ≤2 ng/mL, and receiving a FOLFOX-based regimen were more likely to achieve a pCR to CRT.